We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current APVO market cap is 3.7M. The company's latest EPS is USD -16.5450 and P/E is -0.15.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.38M | -6.98M | -6.02M | -5.21M | -6.38M |
| Net Income | -5.9M | -6.83M | -5.88M | -5.1M | -6.31M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.31M | 12.29M | 3.11M | 0 | 0 |
| Operating Income | -27.49M | -21.4M | -28.64M | -28.88M | -24.6M |
| Net Income | -17.75M | -28.46M | 8.03M | -17.41M | -24.13M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.84M | 17.63M | 14.92M | 15.15M | 15.59M |
| Total Liabilities | 12.62M | 11.53M | 10.46M | 10.73M | 10.84M |
| Total Equity | 12.22M | 6.1M | 4.46M | 4.42M | 4.76M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 53.55M | 56.6M | 34.22M | 24.84M | 15.59M |
| Total Liabilities | 36.95M | 55.39M | 16.24M | 12.62M | 10.84M |
| Total Equity | 16.59M | 1.22M | 17.97M | 12.22M | 4.76M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.73M | -6.65M | -12.8M | -18.03M | -23.79M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 6M | -3k | 3.97M | 8.88M | 15.6M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.32M | -21.68M | -21.02M | -11.73M | -23.79M |
| Investing | 28.03M | -713k | -29k | N/A | N/A |
| Financing | 23.87M | 26.16M | -2.62M | 6M | 15.6M |
| Market Cap | 3.7M |
| Price to Earnings Ratio | -0.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.43 |
| Price to Book Ratio | 0.78 |
| Dividend Yield | - |
| Shares Outstanding | 1.46M |
| Average Volume (1 week) | 58.32k |
| Average Volume (1 Month) | 47.17k |
| 52 Week Change | -99.10% |
| 52 Week High | 399.60 |
| 52 Week Low | 2.54 |
| Spread (Intraday) | 3.02 (54.91%) |
| Company Name | Aptevo Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aptevotherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
